[A new tool for predicting the efficiency of mini-percutaneous nephrolithotomy] [0.03%]
[一种预测迷你经皮肾镜取石术效率的新工具]
M Magomedov D,V Kotov S,A Pulbere S et al.
M Magomedov D et al.
Introduction: Currently, percutaneous nephrolithotomy (PCNL) is a first-line treatment method for large and staghorn kidney stones. Predicting the efficiency of the performed surgical procedure is relevant at the stage of...
P Semenov A,G Usufov A,I Guspanov R et al.
P Semenov A et al.
Introduction: Benign prostatic hyperplasia (BPH) is a condition that occurs in up to 1/3 of men over 50 years of age and can lead to lower urinary tract symptoms (LUTS) requiring surgical treatment. The main adverse event...
[Characterization of the taxonomic structure of testicular and urethral microbiota in men with non-obstructive azoospermia with different outcomes in ART protocols] [0.03%]
[非梗阻性无精子症患者不同辅助生殖技术结局的睾丸和尿道微生物群特征分析]
V Faniev M,A Kadyrov Z,K Druzhinina N et al.
V Faniev M et al.
Aim: To carry out a comparative analysis of the taxonomic structure of the testicular and urethral microbiota of patients with non-obstructive azoospermia (NOA) in ART protocols with positive (live birth) and negative out...
[The study Peptide-ALPHA: a role of bladder regulatory peptides and alpha-blockers in combination therapy for LUTS] [0.03%]
[肽-ALPHA研究：联合治疗LUTS的膀胱调节肽和α受体阻滞剂的作用]
G Spivak L,O Morozov A,R Bogatova S
G Spivak L
Introduction: The pathogenesis of lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH) is quite complex and may be associated with overactive bladder (OAB). Alpha-1-blockers are not effective...
Randomized Controlled Trial
Urologiia (Moscow, Russia : 1999). 2025 Mar:(1):41-46. DOI: 2025
R Kasyan G,I Veliev E,L Grigoryan B et al.
R Kasyan G et al.
Aim: To develop a new practical classification of urinary incontinence (UI) in men based on clinical features and disease severity. Materials and methods:...
Observational Study
Urologiia (Moscow, Russia : 1999). 2025 Mar:(1):34-40. DOI: 2025
[Salvage high-dose brachytherapy in patients with local recurrence of prostate cancer after various types of primary treatment] [0.03%]
前列腺癌各种初次治疗后局部复发的挽救性高剂量率近距离治疗
A Solodkiy V,Yu Pavlov A,G Dzidzaria A et al.
A Solodkiy V et al.
Background: Prostate cancer (PCa) is the second most common cancer worldwide. Current methods of definitive treatment of PCa provide good recurrence-free survival in patients with low and intermediate risk of progression,...
P Sergeev V,A Sergeeva A,D Kochkin A et al.
P Sergeev V et al.
Aim: To discuss the feasibility, safety, and efficiency of conventional laparoscopic partial nephrectomy (LPN) for patients with renal hilar tumors. Mater...
[Efficiency of the biologically active additive Oxaforin in the combined treatment of urolithiasis] [0.03%]
生物活性添加剂欧希澳菲灵治疗尿石症的疗效观察
Y Zubkov A,E Sitdykova M,A Zubkov E
Y Zubkov A
Introduction: Treatment of urolithiasis remains an urgent problem related to medical, social and work rehabilitation. Aim: To evaluate ...
Randomized Controlled Trial
Urologiia (Moscow, Russia : 1999). 2025 Mar:(1):11-16. DOI: 2025
[Drug and behavioral therapy in the treatment of lower urinary tract symptoms that persist after surgical treatment of benign prostatic hyperplasia] [0.03%]
[药物及行为疗法在良性前列腺增生手术后残留下尿路症状治疗中的应用]
V Badakva G,G Yusufov A,A Bogdanov D et al.
V Badakva G et al.
Aim: To evaluate the efficiency of behavioral and drug therapy aimed at reducing the severity of storage symptoms, and to determine the influence of therapy with an anticholinergic drug and a beta-3-adrenergic receptor ag...
Randomized Controlled Trial
Urologiia (Moscow, Russia : 1999). 2025 Mar:(1):5-10. DOI: 2025
A Chislov P,A Lee Y,Kh Ali S et al.
A Chislov P et al.
Urolithiasis (kidney stone disease) remains a significant healthcare challenge worldwide due to its increasing prevalence and high recurrence rates. The rising incidence of urolithiasis can be attributed to the widespread use of advanced im...